non invasive test to determine if defrib is needed Researches, develops and commercializes products for the non-invasive diagnosis of cardiac disease. The company is addressing a key problem in cardiac diagnosis, the identification of those at risk of sudden cardiac death.

Develops, makes and markets sterile biological implant products made from human (allograft) and animal (xenograft) tissue. The company utilizes its Tutoplast process of tissue preservation and viral inactivation to manufacture and deliver sterile bioimplants used in various procedures.

NeoGenomics, Inc. is a high-complexity, CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, hospitals and other reference laboratories throughout the United States. For additional information about NeoGenomics, visit http://www.neogenomics.org.

No Analysis added